Evidence map›Paper›PMID 25539902›Full record

ArticleBrain : a journal of neurology2015

Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET.

Trine Gjerløff, Tatyana Fedorova, Karoline Knudsen, Ole L Munk, Adjmal Nahimi, Steen Jacobsen, Erik H Danielsen, Astrid J Terkelsen, John Hansen, Nicola Pavese and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
6.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 158 citations in OpenAlex.

  1. Lewy body diseases and the gut.Molecular neurodegeneration · 2025
    Review
  2. Management of Gastrointestinal Symptoms in Parkinson's Disease.Journal of central nervous system disease · 2025
    Review
  3. Article
  4. Review
  5. Metformin role in Parkinson's disease: a double-sword effect.Molecular and cellular biochemistry · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Nerve regeneration in transplanted organs and tracer imaging studies: A review.Frontiers in bioengineering and biotechnology · 2022
    Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Trine Gjerløff1 Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Denmark.
Tatyana Fedorova1 Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Denmark.
Karoline Knudsen1 Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Denmark.
Ole L Munk1 Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Denmark.
Adjmal Nahimi1 Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Denmark.
Steen Jacobsen1 Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Denmark.
Erik H Danielsen2 Department of Neurology, Aarhus University Hospital, Denmark.
Astrid J Terkelsen2 Department of Neurology, Aarhus University Hospital, Denmark.
John Hansen3 Department of Health Science and Technology, Aalborg University, Denmark.
Nicola Pavese1 Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Denmark 4 Division of Brain Sciences, Imperial College, London, UK.
David J Brooks1 Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Denmark 4 Division of Brain Sciences, Imperial College, London, UK.
Per Borghammer1 Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Denmark perborgh@rm.dk.
Aarhus University Hospital · DKAalborg University · DKImperial College London · GB

Funding

Medical Research Council
6 · The paper itself

Abstract

Parkinson's disease is associated with early parasympathetic dysfunction leading to constipation and gastroparesis. It has been suggested that pathological α-synuclein aggregations originate in the gut and ascend to the brainstem via the vagus. Our understanding of the pathogenesis and time course of parasympathetic denervation in Parkinson's disease is limited and would benefit from a validated imaging technique to visualize the integrity of parasympathetic function. The positron emission tomography tracer 5-[(11)C]-methoxy-donepezil was recently validated for imaging acetylcholinesterase density in the brain and peripheral organs. Donepezil is a high-affinity ligand for acetylcholinesterase-the enzyme that catabolizes acetylcholine in cholinergic synapses. Acetylcholinesterase histology has been used for many years for visualizing cholinergic neurons. Using 5-[(11)C]-methoxy-donepezil positron emission tomography, we studied 12 patients with early-to-moderate Parkinson's disease (three female; age 64 ± 9 years) and 12 age-matched control subjects (three female; age 62 ± 8 years). We collected clinical information about motor severity, constipation, gastroparesis, and other parameters. Heart rate variability measurements and gastric emptying scintigraphies were performed in all subjects to obtain objective measures of parasympathetic function. We detected significantly decreased (11)C-donepezil binding in the small intestine (-35%; P = 0.003) and pancreas (-22%; P = 0.001) of the patients. No correlations were found between the (11)C-donepezil signal and disease duration, severity of constipation, gastric emptying time, and heart rate variability. In Parkinson's disease, the dorsal motor nucleus of the vagus undergoes severe degeneration and pathological α-synuclein aggregations are also seen in nerve fibres innervating the gastro-intestinal tract. In contrast, the enteric nervous system displays little or no loss of cholinergic neurons. Decreases in (11)C-donepezil binding may, therefore, represent a marker of parasympathetic denervation of internal organs, but further validation studies are needed.

Indexed as

Cholinesterase InhibitorsIndansPiperidinesPositron-Emission TomographyAcetylcholinesteraseAdultAgedAntiparkinson AgentsBrainCase-Control StudiesConstipationDigestive SystemDonepezilFemaleHeart RateHumansAcetylcholinesteraseAntiparkinson AgentsCholinesterase InhibitorsDonepezilIndansPiperidinesacetylcholinesteraseautonomic nervous systemparasympathetic nervous systemParkinson's diseasepositron emission tomography

Identifiers

PMID25539902
PMCPMC4408425
OpenAlexW2014890274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.